Company Name

Sector Amount (in Million USD)

Type of Round

Financing Stage

Ownership Country

Just Medical Co. Ltd.

Medical Technology

14.50 Series A / 1. Round

Equity (private)

Private / independent

China (Mainland)

IotaMotion Inc Medical Technology

2.52 Other Other Private / independent

USA

HiFiBiO SAS Biotechnology - Therapeutics and

Diagnostics

67.00 Series C / 3. Round

Equity (private)

Private / independent

France

Unibio A/S Biotechnology - other

15.00 UD Equity (private)

Private / independent

Denmark

OncoNano Medicine Inc.

Biotechnology - Therapeutics and

Diagnostics

15.40 Other Research grants

Private / independent

USA

EBR Systems Inc.

Medical Technology

30.00 Other Other Private / independent

USA

Boston Microfluidics

Biotechnology / R&D Services

17.50 Series A / 1. Round

Equity (private)

Private / independent

USA

ESSA Pharma Inc.

Biotechnology - Therapeutics and

Diagnostics

36.00 Other Post-IPO Publicly listed on

stock exchange

Canada

E25Bio Inc. Biotechnology / R&D Services

2.30 Other Other Private / independent

USA

Emtora Biosciences

Biotechnology - Therapeutics and

Diagnostics

3.00 Series G / 7. Round

Research grants

Private / independent

USA

Continuus Pharmaceuticals

Biotechnology / R&D Services

5.00 Series B / 2. Round

UD Private / independent

USA

Finch Therapeutics Group Inc.

Biotechnology - Therapeutics and

Diagnostics

53.00 Series C / 3. Round

Equity (private)

Private / independent

USA

Chinook Therapeutics Inc.

Biotechnology - Therapeutics and

Diagnostics

65.00 Series A / 1. Round

Equity (private)

Private / independent

Canada

ONL Therapeutics Inc.

Biotechnology - Therapeutics and

Diagnostics

3.00 Other UD Private / independent

USA

Aperiomics Inc. Biotechnology / R&D Services

1.80 Series A / 1. Round

Equity (private)

Private / independent

USA

Bellicum Pharmaceuticals Inc.

Biotechnology - Therapeutics and

Diagnostics

57.50 Other Post-IPO Publicly listed on

stock exchange

USA

Oncorus Inc. Biotechnology - Therapeutics and

Diagnostics

79.50 Series B / 2. Round

Equity (private)

Private / independent

USA

Rexgenero Limited

Biotechnology - Therapeutics and

Diagnostics

0.33 Other Research grants

Private / independent

United Kingdom

Helix Biopharma Corp.

Biotechnology - Therapeutics and

Diagnostics

7.00 Other UD Publicly listed on

stock exchange

Canada

Altimmune Inc. Biotechnology - Therapeutics and

Diagnostics

3.70 Other Research grants

Publicly listed on

stock exchange

USA

Delcath Systems Inc.

Pharma 9.50 Other Other Publicly listed on

stock exchange

USA

Graybug Vision Inc.

Biotechnology - Therapeutics and

Diagnostics

80.00 Series C / 3. Round

Other Private / independent

USA

Vaxxilon AG Biotechnology - Therapeutics and

Diagnostics

1.40 Other Research grants

Private / independent

Switzerland

Araris Biotech AG

Biotechnology - Therapeutics and

Diagnostics

2.53 UD Equity (private)

Private / independent

Switzerland

Juvenescence Limited

Biotechnology - Therapeutics and

Diagnostics

100.00 Series B / 2. Round

Equity (private)

Private / independent

Isle of Man

Yaoyanshe (Shanghai Mudi Biological Technology Co.Ltd.)

Biotechnology / R&D Services

42.00 Series C / 3. Round

Equity (private)

Private / independent

China (Mainland)

Soligenix Inc. Biotechnology - Therapeutics and

Diagnostics

0.15 Other Research grants

Publicly listed on

USA

stock exchange

NOXXON Pharma N.V

Biotechnology - Therapeutics and

Diagnostics

1.10 Other Post-IPO Publicly listed on

stock exchange

Germany

Monopar Therapeutics Inc.

Biotechnology - Therapeutics and

Diagnostics

40.00 Other IPO Private / independent

USA

Motif FoodWorks Inc.

Biotechnology - other

27.50 Other Other Private / independent

USA

XpectVision Technology Co. Ltd.

Medical Technology

14.00 Series B / 2. Round

Equity (private)

Private / independent

China (Mainland)

AtriCure Inc. Medical Technology

300.00 Other Other Publicly listed on

stock exchange

USA

Deciphera Pharmaceuticals Inc.

Biotechnology - Therapeutics and

Diagnostics

400.00 Other Post-IPO Publicly listed on

stock exchange

USA

Tevosol Inc. Medical Technology

1.50 Other Other Private / independent

Canada

D&D Pharmatech

Biotechnology - Therapeutics and

Diagnostics

137.10 Series B / 2. Round

Other Private / independent

South Korea

DelMar Pharmaceuticals Inc.

Biotechnology - Therapeutics and

Diagnostics

6.70 Other Post-IPO Publicly listed on

stock exchange

USA

Antibe Therapeutics Inc.

Biotechnology - Therapeutics and

Diagnostics

8.00 Other Post-IPO Publicly listed on

stock exchange

Canada

Apollo Endosurgery Inc.

Medical Technology

20.00 Other Debt financing

Publicly listed on

stock exchange

USA

Mustang Bio Biotechnology - Therapeutics and

Diagnostics

9.28 Other UD Publicly listed on

stock exchange

USA

RESPIRIX INC. Medical Technology

1.30 Other Other Private / independent

USA

Landos Biopharma Inc.

Biotechnology - Therapeutics and

Diagnostics

60.00 Series B / 2. Round

Equity (private)

Private / independent

USA

Dynavax Technologies Corporation

Biotechnology - Therapeutics and

Diagnostics

70.10 Other Post-IPO Publicly listed on

stock exchange

USA

InMode Ltd. Medical Technology

70.00 Other IPO Publicly listed on

stock exchange

Israel

Hazel Technologies Inc.

Biotechnology - other

13.00 Other Other Private / independent

USA

CardioMech AS Medical Technology

5.00 Other Convertible loan

Private / independent

Norway

AgroSavfe NV Biotechnology - other

38.65 Series C / 3. Round

Equity (private)

Private / independent

Belgium

Beijing Baicare Biotechnology Co. Ltd.

Biotechnology - Therapeutics and

Diagnostics

9.00 Series B / 2. Round

Equity (private)

Private / independent

China (Mainland)

Novosteo Inc. Biotechnology - Therapeutics and

Diagnostics

0.50 Other Equity (private)

Private / independent

USA

Quanterix Corporation

Biotechnology / R&D Services

60.00 Other UD Publicly listed on

stock exchange

USA

Kangpu Bio-Pharmaceutical Technology (Shanghai) Co. Ltd.

Biotechnology - Therapeutics and

Diagnostics

14.00 Series A / 1. Round

Equity (private)

Private / independent

China (Mainland)

NovaBay Pharmaceuticals Inc.

Biotechnology - Therapeutics and

Diagnostics

2.70 Other Post-IPO Publicly listed on

stock exchange

USA

NovaBay Pharmaceuticals Inc.

Biotechnology - Therapeutics and

Diagnostics

4.20 Other Post-IPO Publicly listed on

stock exchange

USA

SHINE Medical Technologies Inc

Medical Technology

15.00 Other Research grants

Private / independent

USA

Numerate Inc Biotechnology - Therapeutics and

Diagnostics

2.00 Other Research grants

Private / independent

USA

Stemline Therapeutics Inc.

Biotechnology - Therapeutics and

Diagnostics

76.20 Other Post-IPO Publicly listed on

stock exchange

USA

Oric Pharmaceuticals Inc.

Biotechnology - Therapeutics and

Diagnostics

55.00 Series D / 4. Round

Equity (private)

Private / independent

USA

Glycomine Inc. Biotechnology - Therapeutics and

Diagnostics

33.00 Series B / 2. Round

Other Private / independent

USA

Biosignatures Ltd

Biotechnology / R&D Services

4.27 Other Equity (private)

Private / independent

United Kingdom

AIQ Solutions Medical Technology

3.20 Series A / 1. Round

Other Private / independent

USA

ObsEva SA Pharma 75.00 Other Other Publicly listed on

stock exchange

Switzerland

RoosterBio Inc. Biotechnology / R&D Services

15.00 Series B / 2. Round

Equity (private)

Private / independent

USA

SpeeDx Pty. Ltd. Biotechnology / R&D Services

UD Other Equity (private)

Private / independent

Australia

Kineta Inc. Biotechnology - Therapeutics and

Diagnostics

1.80 Other Other Private / independent

USA

Forty Seven Inc. Biotechnology - Therapeutics and

Diagnostics

6.00 Other Research grants

Publicly listed on

stock exchange

USA

Kane Biotech Inc.

Medical Technology

3.80 Other UD Publicly listed on

stock exchange

Canada

Inovio Pharmaceuticals Inc.

Biotechnology - Therapeutics and

Diagnostics

15.00 Other Post-IPO Publicly listed on

stock exchange

USA

Obalon Therapeutics Inc.

Medical Technology

16.60 Other Post-IPO Publicly listed on

stock exchange

USA

Cleave Therapeutics Inc.

Biotechnology - Therapeutics and

Diagnostics

12.00 Other Equity (private)

Private / independent

USA

Advantagene Inc.

Biotechnology - Therapeutics and

Diagnostics

2.00 Other Research grants

Private / independent

USA

Inari Agriculture Biotechnology - other

89.00 Series C / 3. Round

Equity (private)

Subsidiary USA

Lucira Health Inc.

Biotechnology / R&D Services

15.00 Series B / 2. Round

Equity (private)

Private / independent

USA

Sagimet Biosciences

Biotechnology - Therapeutics and

Diagnostics

7.00 Series E / 5. Round

Equity (private)

Private / independent

USA

AlphaTech Biotechnology / R&D Services

57.70 Other Other Private / independent

USA

GNA Biosolutions GmbH

Biotechnology / R&D Services

13.50 Series C / 3. Round

UD Private / independent

Germany

Exo Imaging Inc. Medical Technology

35.00 Series B / 2. Round

Other Private / independent

USA

BioCardia Inc. Medical Technology

10.00 Other IPO Publicly listed on

stock exchange

USA

Arcturus Therapeutics Ltd.

Biotechnology - Therapeutics and

Diagnostics

2.30 Other UD Publicly listed on

stock exchange

USA

Exicure Inc. Biotechnology - Therapeutics and

Diagnostics

63.25 Other IPO Publicly listed on

stock exchange

USA

Exicure Inc. Biotechnology - Therapeutics and

Diagnostics

63.25 Other Post-IPO Publicly listed on

stock exchange

USA

Abcuro Inc. Biotechnology - Therapeutics and

Diagnostics

8.00 Series A / 1. Round

Other Private / independent

USA

Anokion US Inc. Biotechnology - Therapeutics and

Diagnostics

0.00 Series B / 2. Round

Equity (private)

Private / independent

USA

Rewind Therapeutics

Biotechnology - Therapeutics and

Diagnostics

3.20 Other Research grants

Private / independent

Belgium

Prokaryotics Inc.

Biotechnology - Therapeutics and

Diagnostics

2.30 Other Research grants

Private / independent

USA

ImCheck Therapeutics S.A.S

Biotechnology - Therapeutics and

Diagnostics

2.21 Other UD Private / independent

France

Alize Pharma 3 Biotechnology - Therapeutics and

Diagnostics

74.73 Series A / 1. Round

UD Private / independent

France